Intra-Cellular Therapies Inc (ITCI)
85.45
-0.19
(-0.22%)
USD |
NASDAQ |
Nov 21, 16:00
85.51
+0.06
(+0.07%)
After-Hours: 20:00
Intra-Cellular Therapies Profit Margin (Quarterly): -15.03% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -15.03% |
| June 30, 2024 | -10.06% |
| March 31, 2024 | -10.53% |
| December 31, 2023 | -21.73% |
| September 30, 2023 | -19.28% |
| June 30, 2023 | -38.85% |
| March 31, 2023 | -46.50% |
| December 31, 2022 | -50.35% |
| September 30, 2022 | -74.45% |
| June 30, 2022 | -157.2% |
| March 31, 2022 | -207.5% |
| December 31, 2021 | -336.0% |
| September 30, 2021 | -356.0% |
| June 30, 2021 | -361.7% |
| March 31, 2021 | -338.5% |
| December 31, 2020 | -489.4% |
| September 30, 2020 | -748.9% |
| June 30, 2020 | -3.40K% |
| March 31, 2020 | -5.37K% |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -597.6K% |
| September 30, 2017 | -74.37K% |
| June 30, 2017 | -15.48K% |
| March 31, 2017 | -28.27K% |
| December 31, 2016 | -28.08K% |
| September 30, 2016 | -693.8K% |
| June 30, 2016 | -13.50K% |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -37.48K% |
| March 31, 2015 | -672.3K% |
| December 31, 2014 | -42.09K% |
| September 30, 2014 | -5.16K% |
| June 30, 2014 | -2.07K% |
| March 31, 2014 | -2.71K% |
| December 31, 2013 | -971.7% |
| September 30, 2013 | -735.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.37K%
Minimum
Mar 2020
-10.06%
Maximum
Jun 2024
-634.2%
Average
-157.2%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -105.0% |
| AbbVie Inc | 10.80% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.58% |
| Return on Assets | -8.93% |
| Return on Invested Capital | -10.58% |
| Gross Profit Margin (Quarterly) | 91.26% |
| Operating Margin (Quarterly) | -22.18% |
| Return on Net Operating Assets | -52.09% |